Inamed Sues Medicis Over Anti-Wrinkle Patent

Law360, New York (June 1, 2004, 12:00 AM EDT) -- Cosmetic care provider Inamed has sued rival Medicis for patent infringement and filed a complaint with the U.S. International Trade Commission over a wrinkle treatment.

Inamed sued Medicis and its Swedish subsidiary Q-Med in the U.S. District Court for the Southern District of California for infringement of a patent related to Medicis's product to smooth facial wrinkles, called Restylane.

Inamed claims Medicis is infringing U.S. patent no. 4,803,075, issued by the U.S. Patent and Trademark Office on Feb. 7, 1989.

The complaint also charges Medicis and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.